Á lódáil...
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a highly aggressive solid tumor, with a 5-year mortality rate of ~50%. The development of immunotherapies has improved the survival of patients with HNSCC, but, the long-term prognosis of patients with recurrent or metastatic HNSCC remains poor. HNSCC...
Na minha lista:
Main Authors: | , , |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Frontiers Media S.A.
2019-10-01
|
Sraith: | Frontiers in Oncology |
Ábhair: | |
Rochtain Ar Líne: | https://www.frontiersin.org/article/10.3389/fonc.2019.01084/full |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|